Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06659965 · ClinicalTrials.gov registry record
Intravenous Methocarbamol for Acute Pain After Spine Surgery
A clinical trial of Spine Surgery and Multimodal Analgesia, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- 1,270
- Enrollment target
- 1
- Study location
NCT06659965: Completed study of Spine Surgery and Multimodal Analgesia, sponsored by The University of Texas Health Science Center, Houston.
NCT06659965 is a study of Spine Surgery and Multimodal Analgesia that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 1,270 participants, above the 76-participant average among 6 other Spine Surgery trials with a reported enrollment target (1571% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06659965, a study of Spine Surgery and Multimodal Analgesia, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- 1,270 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this target trial emulation is to evaluate the impact of intravenous (IV) methocarbamol on postoperative pain and opioid use in adults undergoing elective spine surgery. The main questions it aims to answer are: * Does IV methocarbamol reduce pain in the 6 hours following surgery? * Does IV methocarbamol decrease the need for opioid pain medications in the same period? Participants who receive IV methocarbamol as part of their routine postoperative care will have their pain scores and opioid consumption tracked for 6 hours after treatment. Pain levels will be measured using standard assessments, and opioid use will be quantified in oral morphine equivalents.
Primary Outcome
The primary outcome of this study is the Time-Weighted Average (TWA) pain score measured over the 6-hour period following treatment assignment. Pain scores are collected using a standardized numerical pain rating scale, ranging from 0 (no pain) to 10 (worst possible pain). These scores are assessed in 15-minute intervals, the standard frequency for Phase I PACU assessments, throughout the 6-hour follow-up period. The TWA pain score is calculated by averaging these pain ratings, giving greater we
Conditions Studied
Interventions
- DRUG Intravenous Methocarbamol
Study Locations (1)
Texas
- Memorial Hermann Health System - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,270 participants |
| Start Date | 2020-01-01 |
| Est. Completion | 2025-06-30 |
What the finished NCT06659965 record still lists
NCT06659965 is an observational study that tracks outcomes without assigning an intervention. Its 1,270 participants enrollment target places it among the larger protocols in the corpus, above the 76-participant average among 6 other Spine Surgery trials with a reported enrollment target (1571% higher).
The record links to 5 conditions, with Spine Surgery appearing as the primary indexed condition, and to 1 intervention - of which Intravenous Methocarbamol is the first listed.
NCT06659965 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06659965 about?
NCT06659965 is a clinical study titled "Intravenous Methocarbamol for Acute Pain After Spine Surgery". The goal of this target trial emulation is to evaluate the impact of intravenous (IV) methocarbamol on postoperative pain and opioid use in adults undergoing elective spine surgery. The main questions it aims to answer are: * Does IV methocarbamol reduce pain in the 6 hours following surgery? * Doe...
What is the current status of trial NCT06659965?
This trial is currently completed. The enrollment target is 1,270 participants. The study started on 2020-01-01. Estimated completion is 2025-06-30.
What conditions does trial NCT06659965 study?
This clinical trial studies the following conditions: Spine Surgery, Multimodal Analgesia, Acute Post Operative Pain, Acute Pain, Postoperative, Postsurgical Pain Management.
What interventions are being tested in trial NCT06659965?
The interventions under investigation include: Intravenous Methocarbamol (DRUG).
Who is sponsoring clinical trial NCT06659965?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06659965 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spine Surgery
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of Magnesium on Neuromonitoring
RECRUITING · Phase 4
-
An Open, Parallel-group, Randomized, Medical Device Study to Assess the Usability and Performance of Surgify HaloTM in Spine Surgery Versus State-of-art (Rosen Burr)
RECRUITING · NA
-
Irrisept Solution for Instrumented Spine Surgery
RECRUITING · NA
-
Perioperative Intravenous Lidocaine or Epidural Anesthesia on Outcomes in Complex Spine Surgery
COMPLETED · NA
-
Influence of Dexmedetomidine on the Evoked Potentials During Spine Surgery
COMPLETED · NA
-
Evaluation of Open-Label Conditioned Placebo Analgesia for Postoperative Opioid Reduction Following Spinal Fusion
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06790641 · 1,270 participants · NA
Pathways to Perinatal Mental Health Equity
- NCT06876246 · 1,270 participants · NA
SBIR/ STTR Family Check-up Online
- NCT03678025 · 1,273 participants · Phase 3
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
- NCT07225504 · 1,275 participants · Phase 3
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI